Biovie (BIVI) EPS (Basic) (2013 - 2026)
Biovie's (BIVI) quarterly EPS (Basic) came in at -$0.78 in Q2 2026, up 67.01% year-over-year from -$0.47 in Q2 2025, and down 11.53% quarter-over-quarter from -$0.7 in Q1 2026.
Powered by 
Analysis
Biovie (BIVI) EPS (Basic) (2013 - 2026) Analysis & Trends
Biovie has disclosed EPS (Basic) across 12 years of filings, most recently posting -$0.78 for Q2 2026.
- In Q2 2026, EPS (Basic) rose 67.01% year-over-year to -$0.78; the TTM figure through Jun 2026 stood at -$3.05 (up 74.82% YoY), while the FY2026 annual figure was -$3.05, up 74.82% from the prior year.
- EPS (Basic) came in at -$0.78 for Q2 2026 at Biovie, down from -$0.7 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.7 in Q1 2026 to a low of -$50.33 in Q4 2022.
- Average EPS (Basic) over 5 years is -$17.83, with a median of -$15.46 recorded in 2024.
- The largest YoY upside for EPS (Basic) was 96.91% in 2022 against a maximum downside of 132.04% in 2022.
- Over 5 years, EPS (Basic) stood at -$50.33 in 2022, then surged by 56.27% to -$22.01 in 2023, then surged by 79.31% to -$4.55 in 2024, then soared by 83.17% to -$0.77 in 2025, then declined by 1.68% to -$0.78 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.78 in Q2 2026, -$0.7 in Q1 2026, and -$0.77 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 0.66 |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.06 |
| 10 | Biovie | 15.09 Mn | 15.09 Mn | - | -0.78 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.78 |
| Mar 31, 2026 | -0.70 |
| Dec 31, 2025 | -0.77 |
| Sep 30, 2025 | -0.98 |
| Jun 30, 2025 | -2.36 |
| Mar 31, 2025 | -1.51 |
| Dec 31, 2024 | -4.55 |
| Sep 30, 2024 | -7.00 |
| Jun 30, 2024 | -10.93 |
| Mar 31, 2024 | -19.99 |
| Dec 31, 2023 | -22.01 |
| Sep 30, 2023 | -29.15 |
| Jun 30, 2023 | -28.05 |
| Mar 31, 2023 | -42.58 |
| Dec 31, 2022 | -50.33 |
| Sep 30, 2022 | -38.28 |
| Jun 30, 2022 | -32.80 |
| Mar 31, 2022 | -28.18 |
| Dec 31, 2021 | -21.69 |
| Sep 30, 2021 | -249.32 |